HFS
REGN icon

HL Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

HL Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$489K Sell
1,190
-63
-5% -$25.9K 0.01% 513
2018
Q4 		$468K Sell
1,253
-169
-12% -$61.9K 0.01% 508
2018
Q3 		$575K Buy
1,422
+169
+13% +$64.3K 0.01% 496
2018
Q2 		$432K Sell
1,253
-20
-2% -$6.25K 0.01% 513
2018
Q1 		$438K Sell
1,273
-5
-0.4% -$1.74K 0.01% 517
2017
Q4 		$480K Sell
1,278
-85
-6% -$34.4K 0.01% 432
2017
Q3 		$609K Hold
1,363
– – 0.01% 447
2017
Q2 		$669K Buy
+1,363
New +$596K 0.01% 411
2017
Q1 		– Sell
-738
Closed -$271K – 689
2016
Q4 		$271K Hold
738
– – 0.01% 578
2016
Q3 		$297K Hold
738
– – 0.01% 539
2016
Q2 		$258K Buy
738
+50
+7% +$19.3K 0.01% 565
2016
Q1 		$248K Buy
688
+28
+4% +$11.5K 0.01% 566
2015
Q4 		$358K Hold
660
– – 0.01% 516
2015
Q3 		$307K Buy
660
+75
+13% +$40.3K 0.01% 522
2015
Q2 		$298K Sell
585
-45
-7% -$22K 0.01% 567
2015
Q1 		$284K Buy
630
+10
+2% +$4.24K 0.01% 581
2014
Q4 		$254K Sell
620
-350
-36% -$138K 0.01% 596
2014
Q3 		$350K Buy
+970
New +$325K 0.01% 501
2013
Q4 		– Sell
-675
Closed -$211K – 649
2013
Q3 		$211K Buy
+675
New +$178K 0.01% 542

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HL Financial Services's REGN Position: Q1 2019 in Review

HL Financial Services reduced its Regeneron Pharmaceuticals (REGN) stake by 5% in Q1 2019, selling an estimated $25.9K and leaving 1,190 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #513.

HL Financial Services first reported a position in REGN in Q3 2013 and has held it in 19 quarters since. The position peaked at $669K in Q2 2017. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • HL Financial Services held 1,190 shares of Regeneron Pharmaceuticals worth $489K as of Q1 2019.
  • HL Financial Services sold 63 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $25.9K.
  • Regeneron Pharmaceuticals made up 0.01% of HL Financial Services's portfolio in Q1 2019, its #513 holding.
  • HL Financial Services first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 19 quarters since.
  • HL Financial Services's Regeneron Pharmaceuticals position peaked at $669K in Q2 2017.
  • 719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.